230 related articles for article (PubMed ID: 25683484)
1. Lysophosphatidylcholine acyltransferase 1 (LPCAT1) upregulation in breast carcinoma contributes to tumor progression and predicts early tumor recurrence.
Abdelzaher E; Mostafa MF
Tumour Biol; 2015 Jul; 36(7):5473-83. PubMed ID: 25683484
[TBL] [Abstract][Full Text] [Related]
2. High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers.
Grupp K; Sanader S; Sirma H; Simon R; Koop C; Prien K; Hube-Magg C; Salomon G; Graefen M; Heinzer H; Minner S; Izbicki JR; Sauter G; Schlomm T; Tsourlakis MC
Mol Oncol; 2013 Dec; 7(6):1001-11. PubMed ID: 23941784
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer.
Lebok P; von Hassel A; Meiners J; Hube-Magg C; Simon R; Höflmayer D; Hinsch A; Dum D; Fraune C; Göbel C; Möller K; Sauter G; Jacobsen F; Büscheck F; Prien K; Krech T; Krech RH; von der Assen A; Wölber L; Witzel I; Schmalfeldt B; Geist S; Paluchoswski P; Wilke C; Heilenkötter U; Terracciano L; Müller V; Wilczak W; Burandt EC
Aging (Albany NY); 2019 Sep; 11(18):7796-7804. PubMed ID: 31533087
[TBL] [Abstract][Full Text] [Related]
4. Differential lysophosphatidylcholine acyltransferase 1 (LPCAT1) expression confers aggressiveness and independently predicts recurrence in bladder urothelial carcinomas.
Abdelzaher Ahmed E; Abdel Bary Abdel-Latif A; Fahmy AM; Elzarrouk Mania I
J Histotechnol; 2021 Dec; 44(4):196-205. PubMed ID: 34378492
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T
J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778
[TBL] [Abstract][Full Text] [Related]
6. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
Shida-Sakazume T; Endo-Sakamoto Y; Unozawa M; Fukumoto C; Shimada K; Kasamatsu A; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2015; 10(3):e0120143. PubMed ID: 25803864
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression.
Morita Y; Sakaguchi T; Ikegami K; Goto-Inoue N; Hayasaka T; Hang VT; Tanaka H; Harada T; Shibasaki Y; Suzuki A; Fukumoto K; Inaba K; Murakami M; Setou M; Konno H
J Hepatol; 2013 Aug; 59(2):292-9. PubMed ID: 23567080
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer.
Mansilla F; da Costa KA; Wang S; Kruhøffer M; Lewin TM; Orntoft TF; Coleman RA; Birkenkamp-Demtröder K
J Mol Med (Berl); 2009 Jan; 87(1):85-97. PubMed ID: 18974965
[TBL] [Abstract][Full Text] [Related]
10. The expression level of lysophosphatidylcholine acyltransferase 1 (LPCAT1) correlates to the progression of prostate cancer.
Zhou X; Lawrence TJ; He Z; Pound CR; Mao J; Bigler SA
Exp Mol Pathol; 2012 Feb; 92(1):105-10. PubMed ID: 22101258
[TBL] [Abstract][Full Text] [Related]
11. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
12. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
13. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
[TBL] [Abstract][Full Text] [Related]
14. LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
Li L; Wang X; Ding Y; Hui N; Su B; Yang M
Eur J Med Res; 2022 Oct; 27(1):216. PubMed ID: 36307879
[TBL] [Abstract][Full Text] [Related]
15. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
16. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing the hormone receptor and HER2 levels in breast cancer: a population-based analysis.
Tas F
Onkologie; 2012; 35(3):95-8. PubMed ID: 22414972
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Lysophosphatidylcholine Acyltransferase 1 and Concomitant Lipid Alterations in Gastric Cancer.
Uehara T; Kikuchi H; Miyazaki S; Iino I; Setoguchi T; Hiramatsu Y; Ohta M; Kamiya K; Morita Y; Tanaka H; Baba S; Hayasaka T; Setou M; Konno H
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S206-13. PubMed ID: 25752890
[TBL] [Abstract][Full Text] [Related]
19. LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways.
Huang Y; Wang Y; Wang Y; Wang N; Duan Q; Wang S; Liu M; Bilal MA; Zheng Y
J Invest Dermatol; 2022 Feb; 142(2):303-313.e9. PubMed ID: 34358528
[TBL] [Abstract][Full Text] [Related]
20. A miR-205-LPCAT1 axis contributes to proliferation and progression in multiple cancers.
Liu F; Wu Y; Liu J; Ni RJ; Yang AG; Bian K; Zhang R
Biochem Biophys Res Commun; 2020 Jun; 527(2):474-480. PubMed ID: 32334831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]